MongoDB's Q1 FY26 beat and raise, with Atlas now 72% of revenue, signals strong acquisition of enterprise workloads, especially as we start to see AI deployment at scale. Architectural advantages over relational databases and product innovation, including Voyage AI, position MongoDB as a leader for AI workloads. Despite a $50M non-Atlas headwind, I believe this is temporary, with comps easing from FY27 onwards. Along with that, consensus estimates for revenue and earnings are also trending higher.
MongoDB is a top pick for 'growth at a reasonable price,' rebounding after a recent 15% dip and strong Q1 earnings. The company leads in non-relational databases, benefiting from secular growth in unstructured data and strong brand recognition. MDB's healthy buyback program, robust cash balance, and balanced growth/profitability profile make it attractive vs. peers.
Atlas drives 72% of MDB's revenues as strong adoption boosts customer growth and underpins raised fiscal 2026 guidance.
Standard Chartered is reportedly facing a lawsuit in Singapore filed by liquidators who are trying to recover money from Malaysia's sovereign wealth fund, 1Malaysia Development Berhad (1MDB). [contact-form-7] The lawsuit alleges that Standard Chartered enabled fraud to be committed against 1MDB more than 10 years ago, Reuters reported Tuesday (July 1).
MDB gains ground with strong Q1 results, AI momentum, and raised guidance, justifying its premium valuation.
Liquidators seeking to recoup misappropriated funds from Malaysia's sovereign wealth fund 1MDB have initiated legal proceedings against Standard Chartered Bank in the High Court of Singapore, they said in a statement dated June 30.
With upgraded authorization, soon federal agencies with security requirements at every level will be able to use MongoDB to deploy, run, and scale modern applications in the cloud NEW YORK , June 30, 2025 /PRNewswire/ -- MongoDB, Inc. (NASDAQ: MDB) today announced its commitment to pursuing Federal Risk and Authorization Management Program (FedRAMP) High and Impact Level 5 (IL5) authorizations for MongoDB Atlas for Government workloads, which will expand its eligibility to manage unclassified, yet highly sensitive, U.S. public sector data. With FedRAMP High authorization, even the most critical government agencies looking to adopt cloud and AI technologies—and to modernize aging, inefficient legacy databases—can rely on MongoDB Atlas for Government for secure, fully managed workloads.
The consensus price target hints at a 34.3% upside potential for MongoDB (MDB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
The mean of analysts' price targets for MongoDB (MDB) points to a 31.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
I previously rated MongoDB a sell due to valuation, but I now believe I was too harsh. Management has raised fiscal 2026 non-GAAP operating profit guidance, but free cash flow conversion remains a notable weakness. I estimate free cash flow will reach $200 million this year, with potential upside if cost efficiencies materialize.
MongoDB's NASDAQ: MDB stock price surged following its FQ1 earnings release, as the results and guidance affirmed the analysts' outlook, prompting them to lift their stock price targets. After a year of waiting for the second wave of AI, the application wave is gaining traction.